NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:
CVS Health Corp., down $2.68 to $70.08.
The health care giant cut its 2023 projections after closing a pair of multi-billion dollar deals that push it deeper into providing care.
Ruth's Hospitality Group Inc., up $5.45 to $21.48.
The parent company of the Ruth’s Chris Steak House chain is being acquired by Darden Restaurants for about $715 million.
Starbucks Corp., down $10.50 to $103.96.
The Seattle-based coffee chain said sales growth in China and North America could moderate as the year progresses.
Estee Lauder Cos. Inc., down $42.52 to $202.70.
The company said its Asian travel retail business is under pressure due to a slower-than-anticipated pandemic recovery.
Kraft Heinz Co., up 80 cents to $40.25.
The maker of Jell-O and Kool-Aid easily beat Wall Street's forecasts and raised its profit outlook.
Eli Lilly & Co., up $26.99 to $431.19.
The pharmaceutical company reported encouraging results from a study of its Alzheimer’s treatment.
Ford Motor Co., down 1 cent to $11.79.
The automaker reported results that beat Wall Street's estimates, swinging into the black from a year earlier loss.
Advanced Micro Devices Inc., down $8.32 to $81.59.
The semiconductor company forecast revenue in the current quarter that fell short of some analysts’ expectations.
Before you consider Kraft Heinz, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kraft Heinz wasn't on the list.
While Kraft Heinz currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
